Fusidic Acid Cream

Print Mail Favorites

Basic Pharma’s fully certified modern facilities and team of specialists have the proven expertise and capabilities to develop, produce, package and distribute pharmaceutical products of premium quality.

Fusidic acid cream

Fusidic acid cream is one of the topical products that Basic Pharma manufactures for small- to medium-scale drug companies. We produce fusidic acid cream that complies with your requirements and the rigorous standards of the pharmaceutical industry. The topical product has been fully developed by our in-house chemists and has undergone the required clinical trials. A full dossier of the product’s research, development and clinical results is available.

Product registration and licensing

Fusidic acid cream has been a registered product of Basic Pharma since January 2012. It is out-licensed in several European countries, with additional licenses to be offered in the near future. Licensing opportunities are available for some territories.

Preparation and dosage

Fusidic acid cream is available from Basic Pharma as a generic product in 20 mg/g dosage. It is prescribed for external use on the infected skin area.
Fusidic acid as antibacterial agent

Fusidic acid is an antibiotic medication used to treat skin infections that are primarily caused by bacteria. As an antibacterial agent, fusidic acid is the active ingredient present in the cream preparation.

Fusidic acid cream is a topical product prescribed for a number of skin infections such as:

• infected wounds
• folliculitis (infection or inflammation of hair follicles)
• infected eczema (inflamed or irritated skin condition)
• paronychia (skin infection around toenails or fingernails)
• impetigo (skin infection common among very young children)

Fusidic acid cream is also an effective treatment for infections that have developed resistance to the antibiotic penicillin.

How fusidic acid works

Fusidic acid does not directly destroy bacteria, but inhibits the bacteria’s production of proteins. Without these essential proteins, bacteria cannot develop or multiply. The human body’s immune system attacks the surviving bacteria, and their reduced numbers eventually die out on their own. When bacteria are not allowed to thrive, the skin infection is therefore successfully treated.